Aardvark Therapeutics, Inc.
AARD
$8.49
-$0.50-5.56%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -6.24% | 105.34% | -10.56% | -4.62% | 764.42% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -10.50% | 949.04% | 84.71% | -61.80% | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | 17.65% | -30.96% | -- |
Total Current Assets | -6.33% | 108.47% | -10.32% | -4.97% | -- |
|
|||||
Total Current Assets | -6.33% | 108.47% | -10.32% | -4.97% | -- |
Net Property, Plant & Equipment | -16.88% | -14.56% | -12.60% | 700.95% | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 18.56% | -30.06% | 1,035.78% | 114.81% | -- |
Total Assets | -6.08% | 102.59% | -7.44% | -3.97% | -- |
|
|||||
Total Accounts Payable | 97.81% | 11.23% | 245.05% | -45.59% | -- |
Total Accrued Expenses | 59.64% | 32.26% | 41.16% | 21.94% | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 6.92% | 15.38% | 4.64% | 199.07% | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 72.52% | 21.29% | 88.63% | -1.92% | -- |
|
|||||
Total Current Liabilities | 72.52% | 21.29% | 88.63% | -1.92% | -- |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -32.14% | -23.81% | -19.08% | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -50.00% | -7.69% | -- | -- | -- |
Total Liabilities | 66.51% | 17.46% | 70.86% | 18.55% | -- |
|
|||||
Common Stock & APIC | 0.30% | 5,825.14% | 9.19% | 10.26% | -- |
Retained Earnings | -21.24% | -15.96% | -17.72% | -9.22% | -- |
Treasury Stock & Other | -106.82% | -- | -- | -- | -- |
Total Common Equity | -9.13% | 375.77% | -18.34% | -9.14% | -21.56% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | 0.00% | -0.07% | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | 0.00% | -0.07% | 188.91% |
|
|||||
Total Common Equity | -9.13% | 375.77% | -18.34% | -9.14% | -21.56% |
Total Preferred Equity | -- | -- | 0.00% | -0.07% | 188.91% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -9.13% | 108.96% | -10.51% | -4.68% | 828.80% |
|